Government has banned the use of serodiagnostic test kits for diagnosis of Tuberculosis in the country, following inaccurate results which could pose a health risk.
Written By Miscellaneous|Last Updated: Jun 19, 2012, 11:15 PM IST|Source: Exclusive
New Delhi: Government has banned the use of serodiagnostic test kits for diagnosis of Tuberculosis in the country, following inaccurate results which could pose a health risk.
"The central government is satisfied that the use of serodiagnostic test kits for diagnosis of tuberculosis are giving inconsistent and improper results leading to wrong diagnosis and their use is likely to involve risk to human beings and whereas safer alternatives are available," said a notification issued by the Ministry of Health and Family Welfare.
The Ministry held that "it is necessary and expedient to prohibit the manufacture, sale, distribution and use of the said test kits in public interest."
The test kits have been banned with immediate effect following exercise of powers conferred by Section 26A of the Drugs and Cosmetic Act, 1940.
The ban follows a negative policy statement issued by the WHO over commercial serodiagnostic tests for tuberculosis stating that "commercial serological tests provide inconsistent and imprecise findings resulting in highly variable values for sensitivity and specificity."
The government had also sent a warning to various states for not using the serodiagnostic tests due to their inaccurate results.
"There is no evidence that existing commercial serological assays improve patient-important outcomes, and high proportions of false-positive and false-negative results adversely impact patient safety.
Overall data quality was graded as very low and it is strongly recommended that these tests not be used for the diagnosis of pulmonary and extra- pulmonary TB," the WHO policy statement concluded.
The WHO serodiagnostic test policy statement clearly recommends that these commercial tests not be used for the diagnosis of pulmonary and extra-pulmonary TB.
It further noted that the "currently available commercial serodiagnostic tests (also referred to as serological tests) provide inconsistent and imprecise findings. There is no evidence that existing commercial serological assays improve patient outcomes, and high proportions of false-positive and false-negative results may have an adverse impact on the health of patients."
Government has already declared tuberculosis (TB) a notifiable disease since May 7 this year, making it mandatory on all private doctors, healthcare providers and clinical establishments treating such patients to report each case of the air-borne disease to government.
The notification of TB cases by all healthcare providers will help patients in getting better access to quality diagnosis and treatment.
This would facilitate early diagnosis, rational treatment, prevention of complications, drug resistance and reduce deaths due to TB.
PTI
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookies Setting
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device and the processing of information obtained via those cookies (including about your preferences, device and online activity) by us and our commercial partners to enhance site navigation, personalise ads, analyze site usage, and assist in our marketing efforts. More information can be found in our Cookies and Privacy Policy. You can amend your cookie settings to reject non-essential cookies by clicking Cookie Settings below.
Manage Consent Preferences
Strictly Necessary Cookies
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work or you may not be able to login.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They are also used to limit the number of times you see an advert as well as help measure the effectiveness of an advertising campaign. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we may not know when you have visited our site, and may not be able to monitor its performance.